Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Creates Canada’s Largest Cannabis Company by Revenue and Increases Tilray’s #1 Leading Cannabis Share by 44% with ~13% Pro Forma Market Share Accelerates Realization of Operating and Cost...
HUNTINGDON, Quebec, May 02, 2023 (GLOBE NEWSWIRE) -- ROSE LifeScience Inc. (“ROSE”), a Québec-based cannabis producer, distributor, and marketer, today announced that it will add HEXO Corp.’s...
Delivered $145.6 Million in Net Revenue and 16th Consecutive Quarter of Positive Adjusted EBITDA Maintained #1 Cannabis Market Share Position in Canada, the Largest Federally Legal Cannabis Market...
Delivered $145.6 Million in Net Revenue and 16th Consecutive Quarter of Positive Adjusted EBITDA Maintained #1 Cannabis Market Share Position in Canada, the Largest Federally Legal Cannabis...
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and...
GATINEAU, Quebec, Dec. 14, 2022 (GLOBE NEWSWIRE) -- HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company”), a leading producer of high-quality cannabis products, today announced that...
This news release constitutes a “designated news release” for the purposes of HEXO’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended...
High Tide Becomes Top Revenue-Generating Cannabis Company in Canada PR Newswire CALGARY, AB, Nov. 22, 2022 Data recently released by New Cannabis Ventures shows that the Company is now the...
Company signs three-year supply agreement with HEXO Corp. to buy bulk cannabis for its expanding retail distribution and increased medical offeringsEntourage to transition away from cultivation as...
This news release constitutes a “designated news release” for the purposes of HEXO’s prospectus supplement dated May 2, 2022 to its short form base shelf prospectus dated May 7, 2021 and amended...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0.88 | 0.88 | 0.88 | 0 | 0 | CS |
| 4 | 0 | 0 | 0.88 | 0.88 | 0.88 | 0 | 0 | CS |
| 12 | 0 | 0 | 0.88 | 0.88 | 0.88 | 0 | 0 | CS |
| 26 | 0 | 0 | 0.88 | 0.88 | 0.88 | 0 | 0 | CS |
| 52 | 0 | 0 | 0.88 | 0.88 | 0.88 | 0 | 0 | CS |
| 156 | -8.08 | -90.1785714286 | 8.96 | 13.16 | 0.85 | 621933 | 6.50927213 | CS |
| 260 | -23.62 | -96.4081632653 | 24.5 | 196 | 0.85 | 1631681 | 29.85470598 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
